Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Efficacy of Combined CD38 and PD1 Inhibition with Isatuximab and Cemiplimab for Relapsed/Refractory NK/T-Cell Lymphoma

Blood blood.2024027109.

https://doi.org/10.1182/blood.2024027109

Published: 2025

Includes: Supplemental data

Journal Articles

Impact of Platelet Transfusion and Bleeding Risk Stratification in Patients with Immune Thrombocytopenia before Procedures: A Nationwide Population-Based Cohort Study

Ka-Won Kang, Yumin Choi, Hyung-Jun Lim, Kunye Kwak, Yoon Seok Choi, Yong Park, Byung Soo Kim, Kwang-Sig Lee, Ki Hoon Ahn

Blood (2024) 144 (Supplement 1): 3942.

https://doi.org/10.1182/blood-2024-194107

Published: 2024

Journal Articles

Real-World Efficacy and Safety of Teclistamab for Patients with Released or Refractory Multiple Myeloma: Korean, Nationwide, Retrospective Analysis of an Named Patient Program

Jun Ho Yi, Jae Hoon Lee, Sung-Hoon Jung, Ji Hyun Lee, Ji Yun Lee, Kihyun Kim, Sung-Soo Park, Chang-Ki Min, Yoon Seok Choi, Min Kyoung Kim, Ho-Young Yhim, Dok Hyun Yoon

Blood (2024) 144 (Supplement 1): 7033.

https://doi.org/10.1182/blood-2024-207611

Published: 2024

Journal Articles

Idiopathic Pancytopenia Caused By Immune Checkpoint Inhibitor

Yongjae Lee, Yoon Seok Choi, Jeong Seok Lee, Minsuk Kwon

Blood (2023) 142 (Supplement 1): 5651.

https://doi.org/10.1182/blood-2023-190739

Published: 2023

Journal Articles

Efficacy of Protac-Based EZH2 Degrader MS1943 in Lymphoid Malignancies: A Comprehensive Study on the Combined Effects of MS1943 and Ibrutinib

Youngwoo Jeon, Yurim Jeong, Minseo Yu, Ra Eun Kim, Yoon Seok Choi, Jung-Yeon Lim

Blood (2023) 142 (Supplement 1): 5787.

https://doi.org/10.1182/blood-2023-178522

Published: 2023

Journal Articles

Isatuximab and Cemiplimab in Relapsed or Refractory Extranodal Natural Killer/T-Cell Lymphoma: A Multi-Center, Open-Labeled Phase II Study (CISL2102/ICING study)

Seok Jin Kim, Sang Eun Yoon, Deok-Hwan Yang, Sung Yong Oh, Yoon Seok Choi, Seong Hyun Jeong, Min Kyoung Kim, Sung-Nam Lim, Junhun Cho, Won Seog Kim

Blood (2023) 142 (Supplement 1): 301.

https://doi.org/10.1182/blood-2023-174476

Published: 2023

Journal Articles

Inflammatory Change of FoxP3 + Regulatory T Cells in Human Acute Graft-Versus-Host Disease: Implication in Immunopathogenesis

Yoon Seok Choi, Na Yeon Seong, Yuri Lee, Jun Soung Park, Cheongin Yang, Minsuk Kwon, Seong Hyun Jeong, Joon Seong Park

Blood (2023) 142 (Supplement 1): 4790.

https://doi.org/10.1182/blood-2023-189607

Published: 2023

Journal Articles

A First-in-Human Phase I Study of AT101, a Novel Anti-CD19 Chimeric Antigen Receptor T Cell Product Targeting a Membrane-Proximal Domain of CD19 in Adults with Relapsed or Refractory B Cell Non-Hodgkin Lymphoma

Blood (2023) 142 (Supplement 1): 2096.

https://doi.org/10.1182/blood-2023-189369

Published: 2023

Journal Articles

Clinical Significance of Epstein-Barr Virus in Peripheral T-Cell Lymphoma, Not Otherwise Specified

So Heun Lee, Hyungwoo Cho, Jin Sook Ryu, Chan-Sik Park, Sang-wook Lee, Yoon Sei Lee, Yoon Seok Choi, Dok Hyun Yoon

Blood (2022) 140 (Supplement 1): 3709–3710.

https://doi.org/10.1182/blood-2022-165020

Published: 2022

Journal Articles

Safety and Effectiveness of Rituximab Biosimilar CT-P10 during Routine Clinical Practice: Final Analysis of a Post-Marketing Surveillance Study in the Republic of Korea

Seok-Goo Cho, Jae-Cheol Jo, Young-Woo Jeon, Dajung Kim, Deok-Hwan Yang, Won Sik Lee, Yoon Seok Choi, Jun Ho Yi, Dok Hyun Yoon, Jee Hyun Kong, Jung-yoon Choe, Sung Hyun Kim, Keum Young Ahn, TaeHong Park, Jeongah Park, Sangeun Han

Blood (2022) 140 (Supplement 1): 10960–10962.

https://doi.org/10.1182/blood-2022-156478

Published: 2022

Journal Articles

Prognostic Significance of Vitamin D Level at Diagnosis in Patients with Peripheral T-Cell Lymphoma

Young Gyu Park, Hyungwoo Cho, Jin Sook Ryu, Chan-Sik Park, Sang-wook Lee, Yoon Sei Lee, Yoon Seok Choi, Dok Hyun Yoon

Blood (2022) 140 (Supplement 1): 9441–9442.

https://doi.org/10.1182/blood-2022-158952

Published: 2022

Journal Articles

CD69 + Bone Marrow-Resident CD8 + T Cells Represent a Functionally Impaired Tumor-Reactive Population and Can be Restored By Blocking PD-1 and Tigit in Multiple Myeloma

Yoon Seok Choi, Yuri Lee, Jun Soung Park, Minsuk Kwon, Seong Hyun Jeong, Jeong Seok Lee, Eui-Cheol Shin, Joon Seong Park

Blood (2022) 140 (Supplement 1): 9941–9942.

https://doi.org/10.1182/blood-2022-166580

Published: 2022

Journal Articles

Risk Stratification for Elderly Patients with Diffuse Large B-Cell Lymphoma Integrating Simplified Geriatric Assessment: A Prospective, Multicenter, Cohort Study

Ho-Young Yhim, Yong Park, Jeong-A Kim, Ho-Jin Shin, Young Rok Do, Joon Ho Moon, Min Kyoung Kim, Won Sik Lee, Dae Sik Kim, Myung-Won Lee, Yoon Seok Choi, Seong Hyun Jeong, Kyoung Ha Kim, Chang-Hoon Lee, Ga-Young Song, Jae-Yong Kwak, Deok-Hwan Yang

Blood (2022) 140 (Supplement 1): 6719–6720.

https://doi.org/10.1182/blood-2022-159929

Published: 2022

Journal Articles

Prognostic Significance of Vitamin D Level in Patients with Multiple Myeloma

Sejin Kim, Hyungwoo Cho, Miyoung Kim, Yoon Seok Choi, Dok Hyun Yoon

Blood (2022) 140 (Supplement 1): 7154–7155.

https://doi.org/10.1182/blood-2022-166387

Published: 2022

Journal Articles

PD-1 Blockade Reinvigorates Bone Marrow CD8 + T Cells from Patients with Multiple Myeloma in the Presence of TGF-β Inhibitors

Minsuk Kwon, MD PhD, Eui-Cheol Shin, MD PhD, Yoon Seok Choi, MD PhD

Blood (2019) 134 (Supplement_1): 3241.

https://doi.org/10.1182/blood-2019-128182

Published: 2019

Journal Articles

A Multicenter Retrospective Analysis of Clinicopathologic Features of Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma

Jun Ho Yi, MD PhD, Lee Gyeong-Won, Young Rok Do, PhD MD, Hong Jung Yong, Cheolwon Suh, Yoon Seok Choi, MD, Seong Yoon Lee, MD, Byeong Seok Sohn, MD PhD, Byung-Su Kim, MD PhD, Seok Jin Kim, MD PhD, Won-Seog Kim

Blood (2018) 132 (Supplement 1): 2909.

https://doi.org/10.1182/blood-2018-99-117880

Published: 2018

Journal Articles

Ex Vivo Evidence for the Combination of Immune Checkpoint Inhibition with TGF-β Blockade to Enhance Anti-Tumor T Cell Responses in Multiple Myeloma

Yoon Seok Choi, MD, Minsuk Kwon, MD, Ik-Chan Song, MD, Deog-Yeon Jo, MD PhD, Eui-Cheol Shin, MD PhD

Blood (2018) 132 (Supplement 1): 3198.

https://doi.org/10.1182/blood-2018-99-117816

Published: 2018

Journal Articles

Comparison of Prognostic Stratification between IPI, PIT, and NCCN-IPI in the Treatment of Nodal Peripheral T-Cell Lymphomas

Ho-Young Yhim, MD PhD, Yong Park, MD, Joon Ho Moon, MD, Ho-Jin Shin, MD PhD, Yoon Seok Choi, MD, Min Kyoung Kim, MD PhD, Dae Sik Kim, MD PhD, Ji Hyun Lee, MD PhD, Won Sik Lee, MD PhD, Young Rok Do, PhDMD, Jun Soo Ham, MD, Seok Jin Kim, MD PhD, Won Seog Kim, MD PhD, Deok-Hwan Yang, MD, Jae-Yong Kwak, MD PhD

Blood (2018) 132 (Supplement 1): 1657.

https://doi.org/10.1182/blood-2018-99-115620

Published: 2018

Journal Articles

Immunologic Characterization of Tumor Antigen-Specific T Cells in Multiple Myeloma: Implication in Immune Checkpoint Blockade

Yoon Seok Choi, MD PhD, Minsuk Kwon, MD, Ik Chan Song, MD, Hyo Jin Lee, MD PhD, Hwan Jung Yun, MD, Deog-Yeon Jo, MD PhD, Eui-Cheol Shin, MD PhD

Blood (2017) 130 (Supplement 1): 4389.

https://doi.org/10.1182/blood.V130.Suppl_1.4389.4389

Published: 2017

Journal Articles

RORγt-Mediated TNF-α Production from Human FoxP3 + Regulatory T Cells Contributes to Tissue Inflammation in Acute Viral Infection

Yoon Seok Choi, MD PhD, Ji Young Moon, MD, Seung Woo Baek, MD, Hyewon Ryu, MD, Ik Chan Song, MD, Hyo Jin Lee, MD PhD, Hwan-Jung Yun, MD, Deog-Yeon Jo, MD PhD, Eui-Cheol Shin, MD PhD

Blood (2016) 128 (22): 1337.

https://doi.org/10.1182/blood.V128.22.1337.1337

Published: 2016

NARROW

Efficacy of Combined CD38 and PD1 Inhibition with Isatuximab and Cemiplimab for Relapsed/Refractory NK/T-Cell Lymphoma

Impact of Platelet Transfusion and Bleeding Risk Stratification in Patients with Immune Thrombocytopenia before Procedures: A Nationwide Population-Based Cohort Study

Real-World Efficacy and Safety of Teclistamab for Patients with Released or Refractory Multiple Myeloma: Korean, Nationwide, Retrospective Analysis of an Named Patient Program

Idiopathic Pancytopenia Caused By Immune Checkpoint Inhibitor

Efficacy of Protac-Based EZH2 Degrader MS1943 in Lymphoid Malignancies: A Comprehensive Study on the Combined Effects of MS1943 and Ibrutinib

Isatuximab and Cemiplimab in Relapsed or Refractory Extranodal Natural Killer/T-Cell Lymphoma: A Multi-Center, Open-Labeled Phase II Study (CISL2102/ICING study)

Inflammatory Change of FoxP3 + Regulatory T Cells in Human Acute Graft-Versus-Host Disease: Implication in Immunopathogenesis

A First-in-Human Phase I Study of AT101, a Novel Anti-CD19 Chimeric Antigen Receptor T Cell Product Targeting a Membrane-Proximal Domain of CD19 in Adults with Relapsed or Refractory B Cell Non-Hodgkin Lymphoma

Clinical Significance of Epstein-Barr Virus in Peripheral T-Cell Lymphoma, Not Otherwise Specified

Safety and Effectiveness of Rituximab Biosimilar CT-P10 during Routine Clinical Practice: Final Analysis of a Post-Marketing Surveillance Study in the Republic of Korea

Prognostic Significance of Vitamin D Level at Diagnosis in Patients with Peripheral T-Cell Lymphoma

CD69 + Bone Marrow-Resident CD8 + T Cells Represent a Functionally Impaired Tumor-Reactive Population and Can be Restored By Blocking PD-1 and Tigit in Multiple Myeloma

Risk Stratification for Elderly Patients with Diffuse Large B-Cell Lymphoma Integrating Simplified Geriatric Assessment: A Prospective, Multicenter, Cohort Study

Prognostic Significance of Vitamin D Level in Patients with Multiple Myeloma

PD-1 Blockade Reinvigorates Bone Marrow CD8 + T Cells from Patients with Multiple Myeloma in the Presence of TGF-β Inhibitors

A Multicenter Retrospective Analysis of Clinicopathologic Features of Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma

Ex Vivo Evidence for the Combination of Immune Checkpoint Inhibition with TGF-β Blockade to Enhance Anti-Tumor T Cell Responses in Multiple Myeloma

Comparison of Prognostic Stratification between IPI, PIT, and NCCN-IPI in the Treatment of Nodal Peripheral T-Cell Lymphomas

Immunologic Characterization of Tumor Antigen-Specific T Cells in Multiple Myeloma: Implication in Immune Checkpoint Blockade

RORγt-Mediated TNF-α Production from Human FoxP3 + Regulatory T Cells Contributes to Tissue Inflammation in Acute Viral Infection

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only